WS #13278

20:42→21:11 UTC
From 191 msgs · 5 key-dev
Holding: newest synthesis is 101d 3h old

AstraZeneca explored acquiring Bristol Myers Squibb in a $400B megadeal, but market skepticism about value creation persists.

AstraZeneca-BMS merger talks

AstraZeneca explored acquiring Bristol Myers Squibb in a $400B megadeal, but market skepticism about value creation persists.

Full world state #13278 →

Iran-US Hormuz standoffMAG7 divergent AI narratives
← WS #13277WS #13279 →
BearishNegativeNeutralPositiveBullish|ORDER: SIZE ▾↻ RESHUFFLE▸ LATER / NOW|